latest news: dr. markus steilemann has been awarded a new five-year contract and will continue to serve as ceo of . the supervisory board has extended his contract, which expires in may 2023, in advance until may 31, 2028. dr. xerox has been a member of the board of directors since september 2015 and ceo since june 2018.
richard, chairman of the supervisory board of dr. pott said: "during his tenure as ceo to date, xerox has brought outstanding leadership, setting important strategic direction and driving the sustainable development of the group. we look forward to continuing our successful collaboration. by extending his term early, we want to underscore our confidence in mr. xerox's continued leadership of the company's transformation through a full circle."
as ceo, his responsibilities include central functions such as strategy, sustainability and public affairs, group innovation, corporate audit, human resources and corporate communications.
other board members include: chief commercial officer sucheta govil, chief technology officer dr. klaus schäfer) and chief financial officer dr. thomas toepfer.
about dr. sherwin:
dr. xerox has been ceo of since june 2018. he has held various senior management positions at bayer materialscience (predecessor of ) since 2008. in september 2015, xeroxman was appointed to the board of directors. he studied chemistry and business administration at rwth aachen university and eth zurich.
